Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Family Medicine

Metastatic Cancer Clinical Trials

A listing of Metastatic Cancer medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.


First 1 2 3 4 Last 

Alabama

Research Site
Birmingham Alabama

Announcing a medical research study for advanced hereditary breast cancer.

View More »

Birmingham Alabama

A clinical trial to evaluate treatments using ruxolitinib, gemcitabine and nab-paclitaxel for patients with Metastatic Cancer or Metastatic Pancreatic Cancer

Arizona

Research Site
Gilbert Arizona

Announcing a medical research study for advanced hereditary breast cancer.

View More »

Scottsdale Arizona

A clinical research study of INCB039110, Gemcitabine and nab-paclitaxel for the treatment of Metastatic Cancer or Metastatic Pancreatic Cancer

Scottsdale Healthcare
Scottsdale Arizona 85258

A Phase 1 clinical study for patients with Non Hematologic Cancers, Metastatic Cancer or Lymphoma

Arkansas

Research Site
Little Rock Arkansas

Announcing a medical research study for advanced hereditary breast cancer.

View More »

Fayetteville Arkansas

A clinical research study of INCB039110, Gemcitabine and nab-paclitaxel for the treatment of Metastatic Cancer or Metastatic Pancreatic Cancer

California

Research Site
La Jolla California

Announcing a medical research study for advanced hereditary breast cancer.

Research Site
Los Angeles California

Announcing a medical research study for advanced hereditary breast cancer.

Research Site
Los Angeles California

Announcing a medical research study for advanced hereditary breast cancer.

Research Site
Stanford California

Announcing a medical research study for advanced hereditary breast cancer.

View More »

Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Los Angeles California 90048

A clinical research study of VS-4718 for the treatment of Non Hematologic Cancers or Metastatic Cancer

Cedars-Sinai Medical Center
Los Angeles California 90048

A Phase 1 clinical study for patients with Non Hematologic Cancers, Metastatic Cancer or Lymphoma

Palo Alto Medical Foundation
Sunnyvale California 94086

A clinical research study of BP31510 monotherapy and BP31510 in combination with chemotherapy for the treatment of Metastatic Cancer, Cancer or Refractory Solid Tumor

Colorado

Research Site
Aurora Colorado

Announcing a medical research study for advanced hereditary breast cancer.

Florida

Research Site
Boca Raton Florida

Announcing a medical research study for advanced hereditary breast cancer.

Research Site
Fort Lauderdale Florida

Announcing a medical research study for advanced hereditary breast cancer.

Research Site
Palm Beach Florida

Announcing a medical research study for advanced hereditary breast cancer.

Research Site
Tampa Florida

Announcing a medical research study for advanced hereditary breast cancer.

View More »

Gainesville Florida

A clinical trial to evaluate treatments using ruxolitinib, gemcitabine and nab-paclitaxel for patients with Metastatic Cancer or Metastatic Pancreatic Cancer

Florida Cancer Specialists
Sarasota Florida 34232

A clinical research study of VS-4718 for the treatment of Non Hematologic Cancers or Metastatic Cancer

Sarasota Florida

A clinical trial to evaluate treatments using ruxolitinib, gemcitabine and nab-paclitaxel for patients with Metastatic Cancer or Metastatic Pancreatic Cancer

Research Site
Tampa Florida 33612

Open Label Extension Study of Conatumumab and AMG 479

Georgia

Drug Studies America
Marietta Georgia 30060

A Double Blind, Randomized, Placebo-Controlled, Parallel Group Study of Sativex Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Relieving Uncontrolled Persistent Chronic Pain in Patients with Advanced Cancer, Who Experience Inadequate Analgesic During Optimized Chronic Opioid Therapy

Memorial University Medical Center
Savannah Georgia 31404

SWOG S1201: A Randomized Phase II Pilot Study Prospectively Evaluating Treatment for Patients Based on ERCC1(Excision Repair Cross-Complementing 1) for Advanced/Metastatic Esophageal, Gastric or Gastroesophageal Junction (GEJ) Cancer

Illinois

Research Site
Chicago Illinois

Announcing a medical research study for advanced hereditary breast cancer.

Research Site
Chicago Illinois

Announcing a medical research study for advanced hereditary breast cancer.

Research Site
Chicago Illinois

Announcing a medical research study for advanced hereditary breast cancer.

Research Site
Chicago Illinois

Announcing a medical research study for advanced hereditary breast cancer.

Sherman Health
Elgin Illinois 60123

SWOG S1201 Phase II Randomized, Pilot Study of FOLFOX Therapy Comprising Oxaliplatin, Leucovorin Calcium, and Fluorouracil Versus Irinotecan Hydrochloride and Docetaxel in Patients With Advanced or Metastatic Esophageal Cancer, Gastric Cancer, or Gastroesophageal Junction Cancer

Research Site
Zion Illinois

Announcing a medical research study for advanced hereditary breast cancer.

View More »

Northwestern University
Chicago Illinois 60611

Patients are needed to participate in a clinical research study of bevacizumab and quality-of-life assessment to evaluate Metastatic Cancer or Unspecified Adult Solid Tumor, Protocol Specific

Indiana

Indianapolis Indiana

A clinical research study of INCB039110, Gemcitabine and nab-paclitaxel for the treatment of Metastatic Cancer or Metastatic Pancreatic Cancer

Kentucky

Research Site
Louisville Kentucky

Announcing a medical research study for advanced hereditary breast cancer.

Maryland

Research Site
Baltimore Maryland

Announcing a medical research study for advanced hereditary breast cancer.

View More »

Baltimore Maryland

A clinical research study of INCB039110, Gemcitabine and nab-paclitaxel for the treatment of Metastatic Cancer or Metastatic Pancreatic Cancer

National Cancer Institute at the National Institutes of Health
Bethesda Maryland 20892

Patients are needed to participate in a clinical research study of Cintredekin besudotox to evaluate Adrenocortical Carcinoma

Massachusetts

Research Site
Boston Massachusetts

Announcing a medical research study for advanced hereditary breast cancer.

Michigan

Research Site
Lansing Michigan

Announcing a medical research study for advanced hereditary breast cancer.

Research Site
Royal Oak Michigan

Announcing a medical research study for advanced hereditary breast cancer.

Missouri

Research Site
St. Louis Missouri

Announcing a medical research study for advanced hereditary breast cancer.

New Jersey

Research Site
New Brunswick New Jersey

Announcing a medical research study for advanced hereditary breast cancer.

New York

Research Site
New York New York

Announcing a medical research study for advanced hereditary breast cancer.

Research Site
New York New York

Announcing a medical research study for advanced hereditary breast cancer.

View More »

Research Site
Buffalo New York 14263

Open Label Extension Study of Conatumumab and AMG 479

Lake Success New York

A clinical research study of INCB039110, Gemcitabine and nab-paclitaxel for the treatment of Metastatic Cancer or Metastatic Pancreatic Cancer

Weill Cornell Solid Tumor Oncology Practice
New York New York 10021

A clinical research study of BP31510 monotherapy and BP31510 in combination with chemotherapy for the treatment of Metastatic Cancer, Cancer or Refractory Solid Tumor

Memorial Sloan Kettering Cancer Center
New York New York 10065

A Phase 1 clinical study for patients with Non Hematologic Cancers, Metastatic Cancer or Lymphoma

First 1 2 3 4 Last